Search results for "Highlights"
SGLT-2 inhibitors reduced risk of cardiovascular disease, death, review finds
The authors of a systematic review and meta-analysis recommended reconsideration of guidelines on sodium-glucose cotransporter-2 (SGLT-2) inhibitors to increase use among patients at risk of cardiovascular disease.
https://diabetes.acponline.org/archives/2020/02/14/3.htm
14 Feb 2020
HbA1c testing in barbershops identified black men with undiagnosed diabetes
About one-third of men approached in barbershops owned by black individuals were willing to be screened for diabetes, and 9% of them had undiagnosed diabetes while 28% had prediabetes.
https://diabetes.acponline.org/archives/2020/02/14/2.htm
14 Feb 2020
Spotlight on the effects of exercise in diabetes
Studies published in the past month looked at how exercise and indicators of fitness among patients with diabetes are associated with mortality risk, vascular health, and medication use.
https://diabetes.acponline.org/archives/2020/02/14/5.htm
14 Feb 2020
Intermittent fasting may be effective weight loss strategy in patients with type 2 diabetes
A systematic review and meta-analysis of seven studies found that intermittent fasting induced a greater decrease in body weight compared to regular diet but was not associated with any greater reduction in HbA1c levels.
https://diabetes.acponline.org/archives/2021/01/08/1.htm
8 Jan 2021
HbA1c level may predict cardiovascular events in high-risk patients with diabetes
Glycemic control as measured by HbA1c level remains strongly and independently associated with cardiovascular outcomes in high-risk patients with diabetes on statin therapy.
https://diabetes.acponline.org/archives/2020/01/10/3.htm
10 Jan 2020
Study finds ‘marked improvements’ in diabetes management from 1999 to 2016
While the proportion of U.S. adults with diabetes who attained glycemic, blood pressure, and lipid control increased during the study period, there was a lack of progress related to dietary guidelines.
https://diabetes.acponline.org/archives/2020/01/10/2.htm
10 Jan 2020
Oral semaglutide led to greater reductions in HbA1c, body weight than sitagliptin
The industry-funded PIONEER 3 trial randomized adults whose type 2 diabetes was uncontrolled with metformin, with or without sulfonylurea, to receive either oral sitagliptin (100 mg/d) or oral semaglutide (3, 7, or 14 mg/d).
https://diabetes.acponline.org/archives/2019/04/05/2.htm
5 Apr 2019
Diabetes apps require additional validation, education on their use, consensus report finds
Clinicians should be aware of the strengths and weaknesses of diabetes apps and be able to advise patients on their use, according to the European Association for the Study of Diabetes and the American Diabetes Association.
https://diabetes.acponline.org/archives/2019/12/13/3.htm
13 Dec 2019
Frequency of outpatient visits for diabetes not associated with glycemic control
The frequency of diabetes visits varied across health systems, but within most of the studied organizations, patients with high HbA1c levels were not seen any more often than those with lower levels.
https://diabetes.acponline.org/archives/2019/12/13/2.htm
13 Dec 2019
Diabetes remission after bariatric surgery may be more likely in younger patients with shorter disease duration
Long-term results from the Longitudinal Assessment of Bariatric Surgery suggested that diabetes remission is more likely after bariatric surgery performed soon after diagnosis, when diabetes medication burden is low and beta-cell function is preserved, study authors noted.
https://diabetes.acponline.org/archives/2020/12/11/1.htm
11 Dec 2020